The Relationship between CPAP Usage and Corneal Thickness
Citation: Gelir E, Budak MT, Ardc S (
The Relationship between CPAP Usage and Corneal Thickness
Ethem Gelir 0
Murat Timur Budak 0
Sadik Ardc 0
Karen L. Gamble, University of Alabama at Birmingham, United States of America
0 1 Physiology Department, Hacettepe University Medical School , Ankara, Turkey, 2 Sleep Laboratory , Pulmonary Medicine Department, SGK Ankara Education Hospital , Ankara , Turkey
The purpose of this study was to determine whether there is a correlation between CPAP usage and corneal thickness in patients with sleep disordered breathing. Full-night polysomnography (PSG) recordings were collected. Ten patients had undergone PSG recordings with continuous positive airway pressure (CPAP), and seven patients had undergone PSG recordings without CPAP. We measured corneal thickness by ultrasonic pachymeter before sleep and ten minutes after waking. We also measured visual acuity with a routine ophthalmologic eye chart before and after sleep. We asked patients to fill out a post-sleep questionnaire to get their subjective opinions. In the without-CPAP group, corneal thickness increased significantly during sleep in both eyes (left, p = 0.0025; right, p,0.0001). In the with-CPAP group, corneal thickness did not increase significantly (p.0.05 for both left and right cornea). There was no significant difference in visual acuity tests (p.0.05 for both left and right eye) between the two groups. According to our results, there is a significant increase in corneal thickness in the without-CPAP group. Our data show that a low percentage of Rapid Eye Movement (REM) sleep may cause an increase in corneal thickness, which can indicate poor corneal oxygenation. In fact, many sleepdisordered breathing (SDB) patients have low REM. Since a contact lens may cause low corneal oxygenation, SDB patients with contact lenses should be monitored carefully for their corneal thickness.
-
SDB is the most common sleep disorder associated with
excessive sleepiness. SDB is characterized by episodes of sleep
apnea (cessation of breathing over 10 s or more) or hypopnea
(significant reduction of breathing), oxygen desaturations, and
frequent arousals [1]. The most common form of SDB is
obstructive sleep apnea (OSA) and is associated with airway
collapse as the cause of breathing cessation or reduction. The
standard, first-line treatment for OSA is continuous positive
airway pressure (CPAP) [2]. CPAP is fan-generated air pressure
delivered via a nasal mask and titrated to offset negative
intrathoracic pressures produced during inhalation. As such,
CPAP acts as a pneumatic splint to maintain airway patency. It
has been shown to be very effective in most patients leading to
improved daytime alertness, cognitive function, and quality of life
[35].
Since the discovery of rapid eye movement (REM) sleep in
1953, it has been established that REM sleep is homeostatically
regulated. Selective REM sleep deprivation produces
compensatory increases in REM on subsequent sleep opportunities [6]. This
phenomenon is commonly called REM rebound. REM
rebound occurs regardless of whether the original REM
suppression was instrumental [7] (i.e., waking subjects up when they
entered REM sleep), pharmacologic [8] (e.g., amitryptaline or
fluoxetine), or disease related [9] (e.g., sleep-related breathing
disorders). Subsequently, researchers have found that in adults,
REM occupies 2025% of total sleep time and many physiologic
changes are associated with REM sleep, including atonia [10],
poikilothermia [11], nocturnal penile tumescence [12,13], middle
ear muscle activity [14], and increased cerebral blood flow [15].
Recently, corneal thickening was added to the list of physiologic
properties affected by REM sleep. The hypothesis was advanced
by Maurice (1998) who proposed that eye movements in REM
sleep help corneal oxygenation. According to Maurice, thermal
circulation of the aqueous humor is needed for adequate corneal
respiration. This circulation is suppressed when the lids are closed,
and REM is required to stir the anterior chamber and thus prevent
corneal anoxia during sleep [16].
Corneal thickness measurements give valuable information
about the physiological status of the cornea [1719]. Healthy
human corneal thickness is around 500 microns [20]. However the
thickness can change under some circumstances, such as hypoxia
and hypercapnia. It has also been shown that corneal thickness
significantly affects intraocular pressure measurement, and may
itself be a risk factor for developing glaucoma [21,22]. Early
studies showed that the normal human cornea would swell by 7%
every hour in an oxygen-free environment [23]. Diurnal variation
of central corneal thickness (CCT) has also been described, with
swelling overnight; this swelling resolved by early afternoon,
suggesting it was caused by the lid closure creating hypoxia [24].
Corneal swelling caused by hypoxia is a well-known phenomenon,
especially in relation to contact lens wear [25]. Long-term use of
contact lenses was shown to alter the following conditions in the
cornea: epithelial oxygen uptake, epithelial thickness, stromal
thickness, and corneal endothelial morphology [26,27].
OSA causes decreased REM sleep percentage and CPAP usage
can usually reverse this decrease. If Maurices hypothesis is right,
then decreased REM percentage should jeopardize corneal
oxygenation. So far, no study has elucidated the relationship
between the CPAP usage and the corneal thickness. Thus, the
purpose of this study was to determine whether a correlation exists
between CPAP use and corneal thickness in patients with OSA.
Materials and Methods
Ethics statement
We obtained Institutional Review Board approval from Baylor
College of Medicine (Houston,TX) for the procedures of the study.
Our study has been carried out in accordance with The Code of
Ethics of the World Medical Association (Declaration of Helsinki)
for experiments involving humans.
Subjects
In this study, patients underwent standardized sleep center
clinical procedures. Men and women, admitted to the Sleep
Laboratory at Baylor College of Medicine, Michael E. DeBakey
Veterans Affairs Medical Center, for overnight polysomnography,
were eligible for this study. Subjects who met the following
inclusion criteria were selected for this study: patients must be
diagnosed with OSA, be 2165 years of age (inclusive), and
provide written informed consent. We excluded patients with eye
(e.g., glaucoma) or neurological (e.g., periodic leg movement)
diseases. Twenty patients participated in the study, subjects were
randomly assigned to one of two groups (10 subjects in each
group). Patients who had used CPAP were called the
withCPAP group, and patients who had not used CPAP were called
the without-CPAP group. However three subjects in the
withCPAP group were excluded because they did not tolerate the
CPAP treatment. All subjects (1 woman and 16 men) were CPAP
nave. The with-CPAP group subjects underwent full-nigh (...truncated)